High Rates of Psoriasis Clearance With Investigational TYK2 Inhibitor

(MedPage Today) -- NEW ORLEANS -- As many as a third of patients with moderate or severe psoriasis had complete clearance within 12 weeks with an investigational oral tyrosine kinase 2 (TYK2) inhibitor, a small randomized trial showed.
From...

Source: MedPage Today Dermatology - March 21, 2023 Category: Dermatology Source Type: news